Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
The British Journal of Ophthalmology
|
May 13, 2026
Suspending vascular endothelial growth factor inhibitors in eyes with retinal vein occlusion
Adrian Robert Hunt, Yohei Hashimoto, Louise O'Toole, et al.
International Journal of Molecular Sciences
|
October 27, 2022
Diagnostic Odyssey in an Adult Patient with Ophthalmologic Abnormalities and Hearing Loss: Contribution of RNA-Seq to the Diagnosis of a PEX1 Deficiency
Gerard Muñoz-Pujol, Socorro Alforja-Castiella, Ricardo Casaroli-Marano, et al.
Plos One
|
January 19, 2024
Next-generation sequencing-based gene panel tests for the detection of rare variants and hypomorphic alleles associated with primary open-angle glaucoma
Elena Milla, Javier Laguna, Mª Socorro Alforja, et al.
Acta Ophthalmologica
|
May 7, 2021
Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry
Pierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, et al.
Ophthalmology. Retina
|
April 19, 2024
Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion: Fight Retinal Blindness!
Socorro Alforja, Adrian Hunt, Vuong Nguyen, et al.
The British Journal of Ophthalmology
|
January 26, 2022
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
Adrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, et al.
Ophthalmology. Retina
|
November 12, 2022
Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF: The Fight Retinal Blindness! Registry
Adrian Hunt, Vuong Nguyen, Sanjeeb Bhandari, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
March 4, 2026
Faricimab for recalcitrant neovascular age-related macular degeneration: A real-life study following Aflibercept nonresponse
Carolina Bernal-Morales, Sol Burgos Herrera, Lena Giralt, et al.
The British Journal of Ophthalmology
|
March 13, 2021
Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry
Adrian R Hunt, Vuong Nguyen, Catherine P Creuzot-Garcher, et al.
Frontiers in Immunology
|
April 18, 2024
C-reactive protein-complement factor H axis as a biomarker of activity in early and intermediate age-related macular degeneration
Lena Giralt, Marc Figueras-Roca, Beatriz De Luis Eguileor, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
The British Journal of Ophthalmology
|
May 13, 2026
Suspending vascular endothelial growth factor inhibitors in eyes with retinal vein occlusion
Adrian Robert Hunt, Yohei Hashimoto, Louise O'Toole, et al.
International Journal of Molecular Sciences
|
October 27, 2022
Diagnostic Odyssey in an Adult Patient with Ophthalmologic Abnormalities and Hearing Loss: Contribution of RNA-Seq to the Diagnosis of a PEX1 Deficiency
Gerard Muñoz-Pujol, Socorro Alforja-Castiella, Ricardo Casaroli-Marano, et al.
Plos One
|
January 19, 2024
Next-generation sequencing-based gene panel tests for the detection of rare variants and hypomorphic alleles associated with primary open-angle glaucoma
Elena Milla, Javier Laguna, Mª Socorro Alforja, et al.
Acta Ophthalmologica
|
May 7, 2021
Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry
Pierre-Henry Gabrielle, Vuong Nguyen, Catherine Creuzot-Garcher, et al.
Ophthalmology. Retina
|
April 19, 2024
Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion: Fight Retinal Blindness!
Socorro Alforja, Adrian Hunt, Vuong Nguyen, et al.
The British Journal of Ophthalmology
|
January 26, 2022
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
Adrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, et al.
Ophthalmology. Retina
|
November 12, 2022
Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF: The Fight Retinal Blindness! Registry
Adrian Hunt, Vuong Nguyen, Sanjeeb Bhandari, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|
March 4, 2026
Faricimab for recalcitrant neovascular age-related macular degeneration: A real-life study following Aflibercept nonresponse
Carolina Bernal-Morales, Sol Burgos Herrera, Lena Giralt, et al.
The British Journal of Ophthalmology
|
March 13, 2021
Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry
Adrian R Hunt, Vuong Nguyen, Catherine P Creuzot-Garcher, et al.
Frontiers in Immunology
|
April 18, 2024
C-reactive protein-complement factor H axis as a biomarker of activity in early and intermediate age-related macular degeneration
Lena Giralt, Marc Figueras-Roca, Beatriz De Luis Eguileor, et al.
Page
of 3